Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 78c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Zimmer Biomet (ZBH) PT Raised to $150 at Oppenheimer Due to MyMobility App Digital Health
August 5, 2020 8:38 AM EDTOppenheimer analyst Steven Lichtman raised the price target on Zimmer Biomet (NYSE: ZBH) to $150.00 (from $138.00) while maintaining a Outperform rating citing COVID-19, solid pull-through, Persona Revision launch, a push into telehealth with the mymobility app, strong demand for ROSA, and low capex... More
